AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $198.47
-
Support level$177.80
-
Resistance level$204.08
-
Beta0.3
-
RSI (14-day)74.7
- Up 6.7 percent, ABBV is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$154.79 | $216.66 | 73.9% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$188.90 | $197.86 | $181.95 | $186.02 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.6%
-
In the next month14.9%
-
In the next year53.7%
Period | Value |
---|---|
Historical (5 year) | 25.1% |
Last month | 24.0% |
Current estimate | 27.9% |
Next month forecast | 26.3% |